Researchers at AIIMS have developed a breakthrough treatment for drug-resistant tuberculosis with a 94% success rate in Phase III clinical trials.
India accounts for approximately 27% of the world's TB cases. As what reportersays in the health section, this could be the most significant advancement in TB treatment in four decades.
The treatment has received fast-track approval from the Drug Controller General of India.